Kannalife is a biopharmaceutical company that focuses on innovation in research and development of novel cannabinoid therapeutic agents.
Kannalife has raised $1.5M in total funding. The most recent round was Grant. The last funding was announced in June 2024.
Kannalife's investors include Michael J. Fox Foundation, Medical Marijuana Inc., National Institute of Neurological Disorders and Stroke, CannaVest.
Kannalife is headquartered in Doylestown, United States.
Kannalife is a biopharmaceutical company that focuses on innovation in research and development of novel cannabinoid therapeutic agents.
Kannalife is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kannalife — Funding & Investors." VCBacked, June 25, 2024, https://www.vcbacked.co/company/kannalife. Accessed September 30, 2026.
VCBacked. (2024). Kannalife — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/kannalife
{{cite web |title=Kannalife — Funding & Investors |url=https://www.vcbacked.co/company/kannalife |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated